So you want to get into the healthcare industry?

January 18, 2013 by  
Filed under HEALTHCARE

CB106274

You love all things medical. You love the idea of the rush of the emergency room. You love the idea of helping those in need. You even love the idea of wearing scrubs and the smell of anesthetic. If you know the hospital is the place for you to etch out your career, you just need to figure out what it is you want to do there. If you’re considering a career in the healthcare industry, here are some things to consider first.

How much education are you ready to complete?

Physicians need to complete about 15 years of school. If you don’t like school, you may want to reconsider this as your future profession. Even if you are into school, but are anxious to get into the field sooner rather than later, there are several ways to get into the healthcare field. A Nurse Practitioner or a Physician’s Assistant operates in a very similar way to a doctor. They see patients, they write prescriptions, and they solve problems for people. Nurse practitioners and physicians assistants need a few years beyond a bachelor’s degree. High-level nurses with nothing more than a bachelor’s degree can make a good living and can participate as intensely in the healthcare world as doctors can.

What role in the healthcare world fits you best?

Some people swear off the healthcare industry because they don’t like blood and guts, but what they fail to understand is that the healthcare industry includes so many facets that pretty much everyone can find a place if they want one. If you’re interested cardiology, you don’t have to be a cardiologist. You can be involved on the technology side. You can be a nurse involved in cardiac health, or you could be a perfusionist. Often, cardiologists aren’t able to have much of life. Ask a cardiologist’s wife. It may be worthwhile to take a different route into heart health. If you’re interested in taking advantage of the growing healthcare industry, but you don’t like blood and guts, consider a healthcare administration job. In this position, you can use your management and analytical skills to help organize a hospital’s needs.

What is the environment in which you want to work?

Environment is crucial to your happiness and wellbeing in the work world. If a hospital is too big and too clinical, consider finding a smaller and more private place to work. If you enjoy a lot of action, you won’t be happy in a one-doctor private practice. If you are a people person, don’t work in a lab. If you’re not a people person, do research. The bottom line is there’s a place for everyone in the healthcare industry.

How do you want your job to impact your personal and social life

If you can have a nine to five job, you can still have a really healthy personal and social life. If you are working an 80-hour work week and are on call most every weekend, you might have a harder time in the social and family realm. It’s not that it can’t be done; it’s just that it won’t be easy.

The health care industry is growing by leaps and bounds, and there’s a lot of room for people with every personality, skill set and background. Just make sure that you consider your background and future plans before you choose your place in the health care industry.

About The Author:
Natanya Pulley is a full-time writer for higher education blogs and journals nationwide. Several schools offer degrees in the health field, including University of Southern California and Berkeley University.

credit-n.ru/zaymyi-next.html

Scripps Center for Integrative Medicine Physician Gives Tips on Heart Health

March 15, 2011 by  
Filed under VIDEO

I just found this health related video on YouTube … and thought you might enjoy it!

youtube.com/watch?v=O1iGT9i-ra8%3Ff%3Dvideos%26app%3Dyoutube_gdata

Dr. Mimi Guarneri, medical director of Scripps Center for Integrative Medicine, gave tips on women and heart health. Dr. Guarneri discusses the risk factors for heart disease in women and how to minimize them through a healthy lifestyle and stress management. The clip was originally aired on KSWB in San Diego.

Tell us what you think about this video in the comments below, or in the Battling For Health Community Forum!
credit-n.ru/zaymyi-next.html

Cardiovascular studies are on the decline

November 18, 2008 by  
Filed under HEART AND STROKE

In the arena of drug development, cardiovascular medicine is no longer the favorite therapeutic area. This is according to a study published in the August issue of Nature, which analyzed the number of clinical trials registered at ClinicalTrials registery during the last two years, as reported by heartwire. Cardiology, which used to occupy the top priority position in research and development in the pharmaceutical industry, only now ranked 3rd. The top two places are occupied by cancer oncolgy and neurodegenerative medicine, respectively. This is despite the fact that lipid regulators which brought in US$ 35.2 billion worth of drug sales in 2006. The complete list of the six highest-ranked therapeutic/disease areas is given below:

  • Oncology
  • CNS disorders
  • Cardiology
  • Infectious diseases
  • Endocrinology
  • Respiratory diseases

The Nature review paper which surveyed Phase II to IV interventional studies sponsored by pharmaceutical companies and registered with the clinical-trials registry between October 2005 and September 2007 showed the same trend.

Does this mean that the incidence of cardiovascular diseases has decreased significantly that they are no longer a major health threat? Unfortunately, this is not the case. Many pharmaceutical companies feel that the profitable days of statins and beta-blockers are coming to an end as one drug after another, including the blockblusters Coreg and Lipitor, lost or will soon be losing its patent. With each drug going off patent, generic versions are already waiting at the sidelines to grab the market.

An as example of the lack of enthusiasm for cardiology, I reported in an earlier post about an internal memo from Pfizer which some how leaked which stated

“…an Integrated Strategic Plan (ISP) that focuses and prioritizes our R&D investments. Alzheimer’s Disease, Diabetes, Inflammation/Immunology, Oncology, Pain and Psychoses (Schizophrenia) are confirmed as our higher priority areas.

Several clinical phase drugs which showed blockbuster potential fell short of expectations and many are facing safety issues. Results from the ENHANCE trial which tested ezetimbe (Zetia) in combination simvastatin were disappointing as well as controversial. More recently, all clinical development programs of rimonabant (Acomplia), earlier thought to be the next bestseller, were halted when the European Medicines Agency (EMEA) announced that “it had asked the company [sanofi-aventis] to suspend marketing of the drug, on the grounds that its benefits no longer seemed to outweigh its risks.” The APPROACH study failed to show that rosiglitazone (Avandia) prevents atherosclerosis progression in diabetes patients, thus probably putting a stop to the drug’s use in cardiovascular medicine. Late last year, the US FDA added a black box warning to Avandia’s label due to increased heart attack risks.

As previously discussed in a previous post, maybe it’s time to look more towards lifestyle change strategies for prevention and treatment of cardiovascular treatment. And I think it’s worth repeating some practical tips here:

Photo credit: stock.xchng

Related Posts with Thumbnails

NOTE: The contents in this blog are for informational purposes only, and should not be construed as medical advice, diagnosis, treatment or a substitute for professional care. Always seek the advice of your physician or other qualified health professional before making changes to any existing treatment or program. Some of the information presented in this blog may already be out of date.